Safe, effective, economical and appropriate rational drug use has become a crucial part of medical services. By summarizing the relevant theoretical research on pharmacoeconomic evaluation systems in recent years, this paper aims to propose a set of operable and easily promotable pharmacoeconomic evaluation paths.
This study mainly adopts literature research, expert consultation, comparative research and other methods to analyze the problems existing in the pharmacoeconomic evaluation system and put forward relevant suggestions.
Currently, there are issues with the relevant theoretical research on the pharmacoeconomic evaluation system in China, including an insufficiently systematic evaluation system, insufficient evaluation dimensions, and isolated data. It is necessary to further improve the evaluation system, enhance the theory of pharmacoeconomics evaluation, and strengthen the generalizability of research results.
This paper proposes a development path of the "policy guidance indicator optimization data-driven" trinity evaluation system, aiming to enrich and improve the pharmacoeconomic evaluation system, enhance the overall efficiency of pharmaceutical resource allocation, and provide useful references for deepening the reform of the medical and health system.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |